发明名称 2-substituted-1,3-thiazole compounds
摘要 The present invention relates to new compounds of formula I, Wherein Y is NR<SUP>4</SUP>CONR<SUP>4</SUP>, NR<SUP>4</SUP>CO, or NR<SUP>4</SUP>; R<SUP>1 </SUP>is nitro or COR<SUP>5</SUP>; R<SUP>2 </SUP>is hydrogen or NH<SUB>2</SUB>; R<SUP>3 </SUP>is C<SUB>1-6</SUB>alkyl or C<SUB>0-6</SUB>alkylaryl wherein C<SUB>0-6</SUB>alkylaryl may be substituted by A; R<SUP>4 </SUP>is hydrogen; R<SUP>5 </SUP>is C<SUB>1-6</SUB>alkyl; A is independently selected from halo, OR<SUP>6 </SUP>and C<SUB>1-6</SUB>alkyl; R<SUP>6 </SUP>is C<SUB>1-6</SUB>alkyl; provided that the compound is not N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea as a free base or a salt thereof as well as a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.
申请公布号 US2005119321(A1) 申请公布日期 2005.06.02
申请号 US20040510846 申请日期 2004.10.12
申请人 BERG STEFAN;HELLBERG SVEN 发明人 BERG STEFAN;HELLBERG SVEN
分类号 C07D277/20;A61K31/426;A61P3/10;A61P5/48;A61P15/00;A61P15/18;A61P17/14;A61P21/04;A61P25/00;A61P25/14;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D277/42;C07D277/46;C07D277/48;C07D277/58;(IPC1-7):C07D277/38 主分类号 C07D277/20
代理机构 代理人
主权项
地址